Name: Kimberly-Clark Corp. (NYSE:KMB) | Analysis of Revenues
Creator: Stock Analysis on Net

Analysis of Revenues

Revenues as Reported

Revenues as Reported

Download chart

Kimberly-Clark Corp., income statement, revenues

US$ in millions

12 months ended:	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Baby and child care products	6,400)	6,300)	6,300)	6,300)	6,400)
Consumer tissue products	6,700)	6,000)	6,000)	5,900)	6,000)
Away-from-home professional products	3,000)	3,300)	3,400)	3,200)	3,100)
All other	3,000)	2,900)	2,800)	2,900)	2,700)
Net sales	19,100)	18,500)	18,500)	18,300)	18,200)

Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31).

Net sales exhibited a gradual upward trajectory between 2016 and 2020, increasing from 18,200 million US$ to 19,100 million US$. While growth remained marginal between 2016 and 2019, a more pronounced increase of 600 million US$ was recorded in the final year of the period.

Consumer Tissue Products: This segment remained relatively stable from 2016 to 2019, fluctuating around the 6,000 million US$ mark. However, a significant surge occurred in 2020, with revenues rising to 6,700 million US$, identifying this segment as a primary driver of the overall net sales increase in the final year.
Baby and Child Care Products: Revenue in this category demonstrated high stability throughout the period, maintaining a tight range between 6,300 million US$ and 6,400 million US$. The segment concluded the period at the same value recorded in 2016, indicating a stagnant but consistent revenue stream.
Away-from-home Professional Products: A divergent trend is observed in this segment, which experienced growth until peaking at 3,400 million US$ in 2018. Subsequently, a decline occurred, with revenues falling to 3,000 million US$ by 2020, resulting in a final value lower than the 2016 baseline.
All Other Revenue Streams: The "All other" category showed a general upward trend, increasing from 2,700 million US$ in 2016 to 3,000 million US$ in 2020, providing a steady contribution to the total revenue growth.

The overall financial pattern suggests a shift in revenue composition by 2020, characterized by a substantial increase in consumer-facing tissue products and a simultaneous contraction in professional away-from-home products.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?